
Condax Medical Products LLC (AKA: Condax LLC) Profile last edited on: 3/13/14
CAGE:
UEI:
Business Identifier: Medical device company specializing in products designed for safe-sex and reduction in erectile dysfunction effects Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
120 Morris Avenue
Rockville Center, NY 11570
Rockville Center, NY 11570
(516) 764-1726 |
info@condaxmedicalproducts.com |
www.condaxmedicalproducts.com |
Location: Multiple
Congr. District: 04
County: Nassau
Congr. District: 04
County: Nassau
Public Profile
Condax Medical Products LLC (CMP) is a medical device company specializing specifically in products designed for safer-sex and to help reduce the effects of erectile dysfunction. The firm was originally founded in order to commercialize a single patent for technology covering a bellows-shaped condom applicator, invented by the founder in 1990. In 2005 several different companies were reorganized and consolidated under one new corporate identity, called Condax Medical Products LLC (CMP). The consolidation substituted former investor interest in only one specific product for a plan where all investors own an interest in all CMP products. The Company has focused all its resources in a single niche: products that promote safer-sexual behavior. CMPâs unique and innovative product array encompasses all aspects of condoms from their formulation to their disposal. In addition, as increasing numbers of men are either unable to produce or have difficulty in sustaining erectile functioning, the company has also pursued a related avenue of interest by developing products to serve the growing erectile dysfunction market. CMP has been awarded 6 peer-reviewed NIH research grants, totaling approximately $7 million, which helped in the development of the ULTIMATE and CONDAX condom applicators and the LEVITRON air-infused cond
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
10-14Revenue Range
1M-1.5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2012 | 1 | NIH | $121,514 | |
Project Title: Effectivenss Of A New Non-Invasive Erectile Support System In Aging Populations | ||||
2002 | 2 | NIH | $783,446 | |
Project Title: Device to Facilitate/Increase Condom Use | ||||
2000 | 1 | NIH | $99,415 | |
Project Title: Effectiveness of Air Infusible Condom to Increase Use | ||||
1998 | 2 | NIH | $784,390 | |
Project Title: Effectiveness of Device to Simplify Increase Condom Use |
Key People / Management
Leon B Kassman -- Founder; Chief Executive Officer
Bruce R Burwick -- Executive Vice President
Armando A Cuervo -- Vice President
Robert J Martin -- President
Steven R Strauss -- Director Of Marketing
Alexander Weinstock -- Principal Investigator
Bruce R Burwick -- Executive Vice President
Armando A Cuervo -- Vice President
Robert J Martin -- President
Steven R Strauss -- Director Of Marketing
Alexander Weinstock -- Principal Investigator
Company News
There are no news available.